Attached files

file filename
EX-31.2 - CERTIFICATION - OptimizeRx Corpf10q0616ex31ii_optimizerx.htm
EX-31.1 - CERTIFICATION - OptimizeRx Corpf10q0616ex31i_optimizerx.htm
10-Q - QUARTERLY REPORT - OptimizeRx Corpf10q0616_optimizerxcorp.htm

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND

CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly Report of OptimizeRx Corp (the “Company”) on Form 10-Q for the quarter ended June 30, 2016 filed with the Securities and Exchange Commission (the “Report”), I, Will Febbo, Chief Executive Officer and I, Douglas Baker, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

 

2.The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.

 

By: /s/ Will Febbo  
Name: Will Febbo  
Title: Principal Executive Officer, and Director  
Date: August 8, 2016  
     
By: /s/ Douglas Baker  
Name: Douglas Baker  
Title: Principal Financial Officer  
Date: August 8, 2016  

 

This certification has been furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.